1. Home
  2. SPCE vs XBIT Comparison

SPCE vs XBIT Comparison

Compare SPCE & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virgin Galactic Holdings Inc.

SPCE

Virgin Galactic Holdings Inc.

HOLD

Current Price

$2.96

Market Cap

331.6M

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.18

Market Cap

70.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCE
XBIT
Founded
2017
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
331.6M
70.1M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
SPCE
XBIT
Price
$2.96
$2.18
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$3.06
N/A
AVG Volume (30 Days)
6.8M
47.0K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
60.84
N/A
EPS
N/A
N/A
Revenue
$1,544,000.00
N/A
Revenue This Year
$2,270.73
N/A
Revenue Next Year
$880.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.13
$2.09
52 Week High
$8.90
$3.44

Technical Indicators

Market Signals
Indicator
SPCE
XBIT
Relative Strength Index (RSI) 51.21 37.39
Support Level $2.84 N/A
Resistance Level $3.39 $2.46
Average True Range (ATR) 0.13 0.06
MACD -0.00 -0.01
Stochastic Oscillator 50.31 13.89

Price Performance

Historical Comparison
SPCE
XBIT

About SPCE Virgin Galactic Holdings Inc.

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: